Several lines of studies have shown that glycogen synthase kinase 3β (GSK-3β), a ubiquitous serine/threonine kinase abundantly expressed in central neuron system, may appear to function in AD and Huntington’s disease (HD) [11, 12]. Here, MARK2 is linked to Huntington disease.